Some of the stocks that may grab investor focus today are:
Wall Street expects Rite Aid Corporation (NYSE: RAD) to report quarterly earnings at $0.04 per share on revenue of $8.23 billion before the opening bell. Rite Aid shares gained 0.83 percent to $8.54 in after-hours trading. Micron Technology, Inc. (NASDAQ: MU) reported better-than-expected profit for its first quarter and issued a strong forecast for the current quarter. Micron shares climbed 9.91 percent to $22.62 in the after-hours trading session. Analysts expect Cal-Maine Foods Inc (NASDAQ: CALM) to post quarterly earnings at $0.48 per share on revenue of $262.83 million after the closing bell. Cal-Maine shares rose 0.12 percent to $42.75 in after-hours trading. Red Hat Inc (NYSE: RHT) reported upbeat earnings for its third quarter, but sales missed expectations. The company also announced that its CFO Frank Calderoni is stepping down. Red Hat shares tumbled 10.15 percent to $71.69 in the after-hours trading session.Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Top Tech Stocks To Buy Right Now: AVG Technologies N.V.(AVG)
Advisors' Opinion:- [By Shane Hupp]
FinnCap cut shares of Avingtrans (LON:AVG) to a corporate rating in a research report report published on Monday.
Shares of LON:AVG opened at GBX 223 ($2.97) on Monday. Avingtrans has a one year low of GBX 174.11 ($2.32) and a one year high of GBX 260 ($3.46).
Top Tech Stocks To Buy Right Now: GAIN Capital Holdings, Inc.(GCAP)
Advisors' Opinion:- [By Shane Hupp]
These are some of the media stories that may have impacted Accern’s scoring:
Get Gain Capital alerts: Gain Capital Holdings Inc (GCAP) Given Average Rating of “Buy” by Brokerages (americanbankingnews.com) Have a grip on these : Harmonic Inc. (NASDAQ:HLIT), GAIN Capital Holdings, Inc. (NYSE:GCAP), Mitcham Industries … (journalfinance.net) Stocks Trending Alert- Ceragon Networks Ltd. (NASDAQ:CRNT), GAIN Capital Holdings, Inc. (NYSE:GCAP), Wheeler … (journalfinance.net) Exclusive: FOREX.com Head of Research James Chen jumps to Investopedia (leaprate.com) GAIN Capital’s GetGo app bolsters Performance tab functionalities (financefeeds.com)Gain Capital opened at $8.19 on Thursday, MarketBeat Ratings reports. The stock has a market capitalization of $369.22 million, a price-to-earnings ratio of -40.95, a PEG ratio of 1.45 and a beta of -0.01. Gain Capital has a 12 month low of $5.66 and a 12 month high of $13.26. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 0.44.
- [By Stephan Byrd]
Gain Capital Holdings Inc (NYSE:GCAP) Director Alex Goor purchased 17,434 shares of the business’s stock in a transaction dated Friday, July 27th. The shares were bought at an average price of $7.50 per share, with a total value of $130,755.00. Following the purchase, the director now directly owns 85,980 shares of the company’s stock, valued at $644,850. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
- [By Stephan Byrd]
Acadian Asset Management LLC bought a new position in shares of Gain Capital Holdings Inc (NYSE:GCAP) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 361,421 shares of the financial services provider’s stock, valued at approximately $2,729,000.
- [By Joseph Griffin]
GAIN Capital (NYSE:GCAP) insider Samantha Roady sold 4,826 shares of GAIN Capital stock in a transaction on Monday, May 7th. The stock was sold at an average price of $8.23, for a total transaction of $39,717.98. Following the completion of the transaction, the insider now owns 221,191 shares in the company, valued at approximately $1,820,401.93. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Top Tech Stocks To Buy Right Now: ImmunoGen, Inc.(IMGN)
Advisors' Opinion:- [By Brian Orelli]
Shares of ImmunoGen (NASDAQ:IMGN) closed down 10.6% on Thursday on no apparent news. The volatile biotech stock is, well, volatile. It's not exactly the first time we've seen a double-digit move on no news.
- [By Stephan Byrd]
Shares of ImmunoGen, Inc. (NASDAQ:IMGN) rose 6.6% during trading on Thursday . The stock traded as high as $11.08 and last traded at $11.04. Approximately 3,157,358 shares changed hands during trading, an increase of 3% from the average daily volume of 3,064,728 shares. The stock had previously closed at $10.36.
- [By Shane Hupp]
ImmunoGen, Inc. (NASDAQ:IMGN) was the target of unusually large options trading activity on Thursday. Stock investors purchased 2,024 put options on the stock. This is an increase of 816% compared to the typical volume of 221 put options.
- [By Joseph Griffin]
Trexquant Investment LP raised its stake in shares of ImmunoGen (NASDAQ:IMGN) by 190.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 331,215 shares of the biotechnology company’s stock after buying an additional 217,244 shares during the quarter. Trexquant Investment LP owned about 0.25% of ImmunoGen worth $3,484,000 at the end of the most recent reporting period.
- [By Joseph Griffin]
ImmunoGen, Inc. (NASDAQ:IMGN) shares traded down 10.6% on Thursday . The company traded as low as $8.59 and last traded at $8.67. 2,407,836 shares changed hands during trading, a decline of 8% from the average session volume of 2,620,787 shares. The stock had previously closed at $9.70.
No comments:
Post a Comment